MedTrace Logo

Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry

NCT03103620 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1027

Last updated 2018-08-07

No results posted yet for this study

Summary

A multi-center, prospective, consecutive enrolled, observational registry. The population being studied includes all patients undergoing treatment of "de novo" lesions in native coronary vessels, saphenous vein graft and/or arterial bypass conduits with the COBRA PzF coronary stent system. The registry will primarily assess the rate of MACE (cardiac death, myocardial infarction and clinically driven target lesion revascularization.

Conditions

  • Stable Angina
  • Unstable Angina
  • ACS - Acute Coronary Syndrome
  • STEMI
  • NSTEMI - Non-ST Segment Elevation MI
  • Myocardial Infarction

Interventions

DEVICE

COBRA PzF Coronary Stent System

COBRA PzF Coronary Stent System

Sponsors & Collaborators

  • AlpinARC

    collaborator UNKNOWN

  • CeloNova BioSciences, Inc.

    lead INDUSTRY

Principal Investigators

  • Luc Maillard, MD · Clinique Axium

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-10
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03103620 on ClinicalTrials.gov